It said that 95% of people with cystic fibrosis in England will now be eligible for modulator therapy. The new drug, also ...

Hundreds of people with cystic fibrosis are to be offered a once-a-day pill which has been hailed as “life changing” by ...

Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue ...

NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...

The Cystic Fibrosis Foundation has agreed to provide Prime Medicine Inc. an additional investment of up to $24 million to ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the ...

NHS England » NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis ...

Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...

A new once daily triple drug treatment for cystic fibrosis is set to be “immediately funded” by NHS England following recommendation from the National Institute for Health and Care Excellence (NICE).1 ...

Axtell spent 15 hours paddleboarding the gap between Bimini and Lake Worth Beach. Although stormy and hot weather made it ...

Licensed for use in the UK in March, Alyftrek will now be immediately funded by the NHS in England. This rapid timeline demonstrates NICE's commitment to getting breakthrough treatments to patients ...